Detalhe da pesquisa
1.
International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial.
BJU Int
; 133(2): 179-187, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463104
2.
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(4): 501-513, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279270
3.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 17(8): 1047-1060, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339115
4.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
Lancet Oncol
; 13(1): 43-54, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22169269
5.
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.
Clin Transl Radiat Oncol
; 37: 130-136, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238579
6.
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018).
Clin Transl Radiat Oncol
; 25: 22-28, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32995575
7.
Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer.
Clin Transl Radiat Oncol
; 10: 1-6, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29928699